However, this effect was inhibited by ARID1A overexpression (Fig. 6I), indicating that one of the mechanisms of ARID1A inhibition on cell survival in SCLC is through blockade of the PI3K/AKT signaling. The gene discussed is AKT1; the disease is small cell lung carcinoma.